• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多药疗法的组成:一项针对 75 岁及以上瑞典人的基于登记的研究。

The composition of polypharmacy: A register-based study of Swedes aged 75 years and older.

机构信息

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet & Stockholm University, Stockholm, Sweden.

Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division for Neurogeriatrics, Karolinska Institutet, Huddinge, Stockholm, Sweden.

出版信息

PLoS One. 2018 Mar 29;13(3):e0194892. doi: 10.1371/journal.pone.0194892. eCollection 2018.

DOI:10.1371/journal.pone.0194892
PMID:29596512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5875802/
Abstract

BACKGROUND

Polypharmacy is common among older adults. However, little is known about the composition of polypharmacy: which are the most frequently used drugs, and how much do these drugs contribute to the overall prevalence of polypharmacy.

METHODS

A total of 822,619 Swedes aged ≥75 years was identified from the Total Population Register. Through record-linkage with the Swedish Prescribed Drug Register and the Social Services Register we could analyze concurrent drug use in the entire population (both individuals living in the community and institution) on the 31 December 2013.

RESULTS

The prevalence of polypharmacy (≥5 drugs) was 45%. The most frequently used drugs were cardiovascular drugs, analgesics, and psychotropics. By excluding the ten most frequently used drug classes or compounds, the prevalence of polypharmacy was reduced by 69% and 51% respectively. The majority of the users of either one of the 10 most frequently used drugs concurrently used at least 4 other drug classes (66%-85%).

CONCLUSION

Almost half of the individuals aged ≥75 years are exposed to polypharmacy in Sweden. A handful of drugs make a large contribution to the overall prevalence of polypharmacy and the majority of drugs prescribed to persons aged ≥75 years are used in combination with other drugs. This highlights the high use of drugs, and the need to consider other concurrent drug treatments when prescribing for older adults.

摘要

背景

老年人普遍存在多种药物治疗的情况。然而,对于多种药物治疗的组成部分,即最常使用的药物有哪些,以及这些药物在多大程度上导致了多种药物治疗的总体流行程度,我们知之甚少。

方法

从总人口登记册中确定了总共 822619 名年龄≥75 岁的瑞典人。通过与瑞典处方药物登记册和社会服务登记册的记录链接,我们可以分析 2013 年 12 月 31 日整个人群(包括居住在社区和机构中的个体)的同时用药情况。

结果

多种药物治疗(≥5 种药物)的患病率为 45%。最常使用的药物是心血管药物、镇痛药和精神药物。如果排除十种最常使用的药物类别或化合物,多种药物治疗的患病率分别降低了 69%和 51%。这十种最常使用的药物中的任何一种药物的使用者,有 66%-85%的人同时使用至少四种其他药物类别。

结论

瑞典有近一半年龄≥75 岁的人存在多种药物治疗的情况。少数几种药物对多种药物治疗的总体流行程度有很大贡献,并且为≥75 岁的人开具的大多数药物都与其他药物联合使用。这突出表明药物的使用量很高,在为老年人开处方时需要考虑其他同时进行的药物治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb1/5875802/691b771f8f75/pone.0194892.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb1/5875802/657b02dbddee/pone.0194892.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb1/5875802/691b771f8f75/pone.0194892.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb1/5875802/657b02dbddee/pone.0194892.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb1/5875802/691b771f8f75/pone.0194892.g002.jpg

相似文献

1
The composition of polypharmacy: A register-based study of Swedes aged 75 years and older.多药疗法的组成:一项针对 75 岁及以上瑞典人的基于登记的研究。
PLoS One. 2018 Mar 29;13(3):e0194892. doi: 10.1371/journal.pone.0194892. eCollection 2018.
2
Remaining Life Expectancy With and Without Polypharmacy: A Register-Based Study of Swedes Aged 65 Years and Older.使用和不使用多种药物治疗情况下的剩余预期寿命:一项基于瑞典65岁及以上老年人登记信息的研究。
J Am Med Dir Assoc. 2016 Jan;17(1):31-5. doi: 10.1016/j.jamda.2015.07.015. Epub 2015 Sep 2.
3
The impact of increasing polypharmacy on prescribed drug expenditure-a register-based study in Sweden 2005-2009.增用多种药物对处方药支出的影响——瑞典 2005-2009 年基于登记的研究。
Health Policy. 2013 Feb;109(2):166-74. doi: 10.1016/j.healthpol.2012.09.005. Epub 2012 Nov 26.
4
Institutionalization as a risk factor for inappropriate drug use in the elderly: a Swedish nationwide register-based study.机构化作为老年人不适当药物使用的风险因素:一项瑞典全国基于登记的研究。
Ann Pharmacother. 2012 Mar;46(3):339-46. doi: 10.1345/aph.1Q597. Epub 2012 Feb 7.
5
Association between prescribed antidepressants and other prescribed drugs differ by gender: a nationwide register-based study in Sweden.处方抗抑郁药与其他处方药之间的关联因性别而异:瑞典一项基于全国登记的研究。
Nord J Psychiatry. 2019 Jan;73(1):73-79. doi: 10.1080/08039488.2018.1536766. Epub 2019 Jan 19.
6
The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people.教育水平对多重用药及不适当用药的影响:一项基于登记系统对60多万老年人的研究。
J Am Geriatr Soc. 2009 Jan;57(1):62-9. doi: 10.1111/j.1532-5415.2008.02040.x. Epub 2008 Nov 14.
7
Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population-based estimates.老年人潜在不适当用药情况:基于人群估计的不同明确标准的全国性比较。
Br J Clin Pharmacol. 2015 Aug;80(2):315-24. doi: 10.1111/bcp.12615. Epub 2015 May 26.
8
Antidepressant prescription patterns and CNS polypharmacy with antidepressants among children, adolescents, and young adults: a population-based study in Sweden.抗抑郁药处方模式与儿童、青少年和年轻成年人中枢神经药物联用:瑞典一项基于人群的研究。
Eur Child Adolesc Psychiatry. 2019 Aug;28(8):1137-1145. doi: 10.1007/s00787-018-01269-2. Epub 2019 Jan 19.
9
Prevalence of purchase of antihypertensive and serum lipid-reducing drugs in Sweden--individual data from national registers.瑞典抗高血压药物和降血脂药物的购买患病率——来自国家登记处的个体数据。
Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):37-42. doi: 10.1002/pds.1515.
10
Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.痴呆患者的精神药物联合使用:患病率及预测因素
J Alzheimers Dis. 2017;56(2):707-716. doi: 10.3233/JAD-160828.

引用本文的文献

1
The Prevalence of Polypharmacy and the Contribution of Age, Period, and Cohort Effects in Sweden From 2006 to 2020.2006年至2020年瑞典多重用药的患病率以及年龄、时期和队列效应的影响
Health Sci Rep. 2025 May 19;8(5):e70778. doi: 10.1002/hsr2.70778. eCollection 2025 May.
2
Commonly prescribed multi-medication therapies exert sex-specific effects on Alzheimer's disease pathology and metabolomic profiles in App mice: Implications for personalized therapeutics in aging.常用的多药联合疗法对App小鼠的阿尔茨海默病病理和代谢组学特征具有性别特异性影响:对衰老个性化治疗的启示。
Alzheimers Dement. 2025 Mar;21(3):e70081. doi: 10.1002/alz.70081.
3

本文引用的文献

1
Determinants of change in polypharmacy status in Switzerland: the population-based CoLaus study.瑞士多重用药状况变化的决定因素:基于人群的洛桑心脏研究
Eur J Clin Pharmacol. 2017 Sep;73(9):1187-1194. doi: 10.1007/s00228-017-2288-1. Epub 2017 Jun 21.
2
Drug use among complete responders, partial responders and non-responders in a longitudinal survey of nonagenarians: analysis of prescription register data.百岁老人纵向调查中完全缓解者、部分缓解者和无缓解者的药物使用情况:处方登记数据的分析
Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):152-161. doi: 10.1002/pds.4120. Epub 2016 Oct 28.
3
Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Prescribing patterns in people living with dementia in the community: A cross-sectional study.
社区中痴呆症患者的处方模式:一项横断面研究。
Australas J Ageing. 2025 Mar;44(1):e13380. doi: 10.1111/ajag.13380. Epub 2024 Oct 27.
4
Trends in Drug Duplications in Swedish Older Adults: A Nationwide Register Study from 2006 to 2021.瑞典老年人群体中药物重复使用的趋势:一项 2006 至 2021 年的全国登记研究。
Drugs Aging. 2024 Sep;41(9):775-781. doi: 10.1007/s40266-024-01145-6. Epub 2024 Sep 13.
5
Pre-clinical Models for Geriatric Pharmacotherapy.老年病药理学的临床前模型。
Drugs Aging. 2024 Aug;41(8):633-640. doi: 10.1007/s40266-024-01129-6. Epub 2024 Jul 9.
6
Number of medically prescribed pharmaceutical agents as predictor of mortality risk: a longitudinal, time-variable analysis in the EPIC-Heidelberg cohort.医学处方药物种类与死亡风险的关系:EPIC-Heidelberg 队列的纵向、时变分析。
Sci Rep. 2024 Jan 2;14(1):106. doi: 10.1038/s41598-023-50487-5.
7
Prevalence of polypharmacy among older adults in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚老年人中多药治疗的流行情况:系统评价和荟萃分析。
Sci Rep. 2023 Oct 17;13(1):17641. doi: 10.1038/s41598-023-45095-2.
8
Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011-2020).多重用药及其相关因素:西班牙老年人群(2011 - 2020年)的性别视角
Front Pharmacol. 2023 Apr 21;14:1189644. doi: 10.3389/fphar.2023.1189644. eCollection 2023.
9
Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based Study.药物-药物相互作用与急诊住院风险:一项全国范围内基于人群的研究。
Drug Saf. 2023 May;46(5):449-456. doi: 10.1007/s40264-023-01283-7. Epub 2023 Apr 12.
10
Polypharmacy Pattern in Iran: A Comprehensive Analysis of a Large Prescription Database.伊朗的多重用药模式:对一个大型处方数据库的综合分析
Iran J Pharm Res. 2023 Feb 17;21(1):e131304. doi: 10.5812/ijpr-131304. eCollection 2022 Dec.
90岁及以上患与未患阿尔茨海默病者的药物使用情况。
Age Ageing. 2016 Nov;45(6):900-904. doi: 10.1093/ageing/afw141. Epub 2016 Sep 8.
4
Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis.减少多重用药策略对临床相关终点的影响:一项系统评价和荟萃分析
Br J Clin Pharmacol. 2016 Aug;82(2):532-48. doi: 10.1111/bcp.12959. Epub 2016 May 7.
5
Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011.2005年与2011年美国老年人处方药、非处方药及膳食补充剂使用情况的变化
JAMA Intern Med. 2016 Apr;176(4):473-82. doi: 10.1001/jamainternmed.2015.8581.
6
Registers of the Swedish total population and their use in medical research.瑞典总人口登记册及其在医学研究中的应用。
Eur J Epidemiol. 2016 Feb;31(2):125-36. doi: 10.1007/s10654-016-0117-y. Epub 2016 Jan 14.
7
Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency.高龄与药物处方:更多的年限,更少的药物?来自意大利药品管理局的全国性报告。
J Am Med Dir Assoc. 2016 Feb;17(2):168-72. doi: 10.1016/j.jamda.2015.08.009.
8
Rapid decrease in length of stay in institutional care for older people in Sweden between 2006 and 2012: results from a population-based study.2006年至2012年间瑞典老年人机构护理住院时间的快速缩短:一项基于人群的研究结果
Health Soc Care Community. 2016 Sep;24(5):631-8. doi: 10.1111/hsc.12237. Epub 2015 May 5.
9
The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010.多重用药及药物相互作用的上升趋势:1995 - 2010年人群数据库分析
BMC Med. 2015 Apr 7;13:74. doi: 10.1186/s12916-015-0322-7.
10
Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people.多重用药与衰弱:法国2350名老年人样本中的患病率、关系及对死亡率的影响
Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):637-46. doi: 10.1002/pds.3772. Epub 2015 Apr 8.